Tag #Out-Of-Pocket Costs

Showing 1 to 1 of 1 results

forbes.com
🌐 85% Global Worthiness
News related image

IRA's Impact: Lower Drug Costs for Medicare Cancer Patients

The Inflation Reduction Act capped annual out-of-pocket costs for Medicare Part D prescription drugs at $3,300 in 2024 and $2,000 in 2025, resulting in a 50% year-over-year increase in oncology prescription volumes between 2023 and 2024, significantly benefiting cancer patients.

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results